A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
一项 II/III 期多中心、随机、开放标签研究,旨在比较来那度胺与研究者选择的药物在复发或难治性弥漫性大 B 细胞淋巴瘤患者中的疗效和安全性。
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-16-2818
Czuczman, Myron S; Trněný, Marek; Davies, Andrew; Rule, Simon; Linton, Kim M; Wagner-Johnston, Nina; Gascoyne, Randy D; Slack, Graham W; Brousset, Pierre; Eberhard, David A; Hernandez-Ilizaliturri, Francisco J; Salles, Gilles; Witzig, Thomas E; Zinzani, Pier Luigi; Wright, George W; Staudt, Louis M; Yang, Yandan; Williams, P Mickey; Lih, Chih-Jian; Russo, Jacqueline; Thakurta, Anjan; Hagner, Patrick; Fustier, Pierre; Song, Dale; Lewis, Ian D